ArticleAnnals of the Royal College of Surgeons of England2026
A national survey of the diagnosis and management of Ménière's disease among ENT consultants, UK.
Article in Annals of the Royal College of Surgeons of England, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMénière's disease (MD) is a rare condition whose diagnosis can be challenging. The American Academy of Otorhinolaryngology-Head and Neck Surgeons (AAO-HNS) has published new guidance to facilitate the diagnosis of MD. We surveyed ear, nose and throat (ENT) consultants in the United Kingdom (UK) to assess their confidence in diagnosing MD, their use of the AAO-HNS guidance and current diagnostic and treatment approaches.
methodsAn online questionnaire was distributed. It asked respondents to anonymously rank their confidence in diagnosing MD, identify the minimum investigations required to make a diagnosis, describe their use of the AAO-HNS criteria, share their preferred treatment for acute attacks and state first- and second-line preventative treatment options.
resultsA total of 86 responses were collected. In total, 88% of respondents reported high levels of confidence in diagnosing MD. Most respondents (29.1%) stated the minimum tests required were 'history', 'otoscopy', 'pure tone audiometry' and 'MRI' (magnetic resonance imaging), although some chose as few as one test (3.49%) and others up to seven (1.2%). Regarding use of the AAO-HNS criteria, responses ranged from 'always' (34.9%) to 'never' (20.9%). Prochlorperazine was the first-line treatment for acute attacks for 81.4% of respondents. Betahistine (38.4%) and dietary restrictions (37.2%) were recommended almost equally as first-line preventative measures. The most popular second-line measure was intratympanic steroids (34.9%), followed by betahistine (24.4%).
conclusionOur survey revealed wide disparities in the diagnosis and management of MD by ENT consultants in the UK, and AAO-HNS guidelines were not universally used. We propose developing greater consensus and intend to conduct a similar international survey to gather a broader perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.